(Q78066986)
Statements
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team (English)
G H Friedland
R Pollard
B Griffith
M Hughes
G Morse
R Bassett
W Freimuth
L Demeter
E Connick
T Nevin
1 August 1999